Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Upcoming SlideShare
What to Upload to SlideShare
What to Upload to SlideShare
Loading in …3
×
1 of 1

SciTech Development Board of Advisors

0

Share

Download to read offline

SciTech Development has a strong and experienced Board of Advisors comprised of pharmaceutical and biotech company executives, senior product development managers, and highly skilled clinicians and scientists. SciTech's advisory board includes:
(1) Brian Leyland-Jones, MD, PhD
Avera Cancer Institute, Chief Medical Officer & Scientific Advisory Board Member for the National Foundation for Cancer Research (NFCR).
(2) John Doux, MD, MBA, Palo Alto Investors, Funded development of Valchlor® for Ceptaris (CTCL drug).
(3) Gregory Kalemkerian, MD, Professor of Medicine, University of Michigan, small cell lung cancer specialist, experience administering fenretinide to humans, Principal Investigator for SciTech’s Phase 1 SCLC clinical trial.
(4) Timothy Kuzel, MD, FACP, Professor of Medicine & Chief, Division of Hematology/Oncology/Cell Therapy, Rush University. Medical Center (Chicago), T-cell lymphoma specialist, Principal Investigator for SciTech’s Phase 1 T-cell lymphoma trial.
(5) Kenneth Massey, PhD, Senior Director, Venture Development, Wayne State University, Former Director, Development Operations & Senior Scientist, Pfizer.
(6) Steve Munk, PhD, Deputy Director, The Biodesign Institute, ASU, previous CEO, Ash Stevens, Inc., oncology drug manufacturing, Managed FDA manufacturing approval for notable oncology drugs: Velcade,® Clolar® & Vidaza.®

Related Books

Free with a 30 day trial from Scribd

See all

Related Audiobooks

Free with a 30 day trial from Scribd

See all

SciTech Development Board of Advisors

  1. 1. SciTech Development, LLC 281 Kercheval Avenue Grosse Pointe Farms, MI 48236 T: (313) 938-5517 W: www.SciTechDevelopment.com Board of Advisors SciTech has a strong and experienced Board of Advisors comprised of pharmaceutical and biotech company executives, senior product development managers, and highly skilled clinicians and scientists. They are: • Additional Key Opinion Leaders (KOLs) are preparing to join the SciTech Team.

×